+44 (0) 20 7549 9987 | USA callers: +1 212 220 8419

Contact Us Now

“Global office based lab market will cross 10.0 billion revenues by 2030”, says Visiongain

23 January 2020

Visiongain’s new report the Office Based Lab Market Forecast 2020-2030: Forecasts by Modality (Single Specialty, Multi-Specialty) By Service (Peripheral Vascular Intervention, Endovascular Interventions, Cardiac, Interventional radiology, Venous, Others), by Specialty (Vascular Surgeons, Interventional Radiologists, Interventional Cardiologists, Others) plus analysis of leading companies indicates that the global office based lab market will cross 10.0 billion revenues by 2030.

The growing trend of surgical procedures in ambulatory settings, driven by the rising occurrence of various vascular diseases, is one of the major factors driving U.S. demand for Office-based laboratories (OBL). In addition, high patient satisfaction is expected to boost the market with a focused and dedicated team of doctors.

Several service providers are available in the country, such as National Cardiovascular Partners and Envision Healthcare and Surgery Partners, and have provided patients with an affordable cost of office-based surgical solutions and services. In fact, key companies including Philips Healthcare & Siemens Healthineers have collaborated with physicians to set up OBLs, equip laboratories with the requisite instruments and provide integrated solutions from start to finish, which are expected to drive the market forward.

The global OBL industry is facing challenges such as limited availability of anesthetic tools and services that may jeopardize patient safety, and lack of technical expertise for minimally invasive surgical procedures. The lack of definitive training and education programs for the use of MIS devices makes surgeons unwilling to use this technology in OBL settings.

Single-specialty OBLs provide more patient-centered services with minimal risk of corporate partner divestment. On the other hand, hybrid models offer greater flexibility under one roof with multiple facilities. The high cost of setting up such laboratories, however, may restrict their establishment. Multi-specialty laboratories are also becoming more common as a collaboration between three and five physicians.

The interventional radiologists segment is expected to see lucrative growth during the forecast period with growing acceptance of minimally invasive procedures in office settings. Similar to vascular surgeons, interventional radiologists participate in more complicated procedures such as coil embolization.

The definition of OBLs was embraced and applied most commonly in the U.S. Today, about 70% of surgical procedures are conducted in ambulatory settings, of which about 25% of the procedures are done in the office of a doctor. The idea of OBL was developed specifically to concentrate on vascular surgery in the office setting, providing patients with more effective treatment at a lower cost. Due to the high incidence of atherosclerosis in the country and a large number of balloon angioplasty and stenting procedures in patients with blocked arteries and veins, peripheral vascular interventions (PVI) dominated the market in services.

This market's supplier environment can be classified into three different sectors: manufacturers of medical imaging equipment, manufacturers of vascular intervention equipment and service providers providing physicians end-to-end solutions to set up laboratories.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Press Release: Peripheral Vascular Device Market Report 2024-2034

The global Peripheral Vascular Devices market is estimated at US$12.49 billion in 2024 and is projected to grow at a CAGR of 8.5% during the forecast period 2024-2034.

30 April 2024


Press Release: Drug Delivery Technologies Market Report 2024-2034

The global Drug Delivery Technologies market is estimated at US$1,729.6 billion in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period 2024-2034.

23 April 2024


Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034

The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.

18 April 2024


Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034

The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.

17 April 2024